Revista de Gastroenterología del Perú - Volumen 20, Nº3 2000


REFERÊNCIAS

1. LEE Y-M, KAPLAN MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-33.
2. LAZARIDIS KN, WIESNER RH, PORAYKO MK, LUDWIG J, LARUSSO NF. Primary sclerosing cholangitis. In Schiff ER, Sorrell MF, Maddrey WC. Schiff's Diseases of the liver. 811, ed, vol. 1, Lippincott Raven Publishers, Philadelphia & New York, 1999, pág. 649-667.
3. BARTHOLOMEW LG, CAIN JC, WOOLNER LB, UTZ DC, FERRIS, DO. Sclerosing cholangitis. Its possible association with Riedel's struma and fibrosis ret rope ritonitis - Report of two cases. N Engl J Med 1963; 269: 8-12.
4. MACCARTHY RL, LARUSSO NF, WIESNER RH, LUDWIG J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983; 149: 39-44.
5. WIESNER RH, LARUSSO NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79:200-6.
6. HELZBERG JH, PETERSEN JM, BOYER JL. Improved survival with primary sclerosing cholangitis: a review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987; 92: 1869-75.
7. LEBOVICS E, PALMER M, WOO J, SCHAFFNER F. Outcome of primary sclerosing cholangitis: analysis of long-term observation of 38 patients. Arch Intern Med 1987; 147: 729-31.
8. FAUSA O, SCHRUMPF E, ELGJO K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 31-9.
9. OLSSON R, DANIELSSON A, JARNEROTH G, et al. Prevalence of primary sclerosing cholangitis in ulcerative colitis. Gastroenterology 1991; 100: 1319-23.
10. SCHRUMPF E, FAUSA O, ELGIO K, KOLMANSKOG F. Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 1988; 8: 201-9.
11. BRENTNALL TA, HAGGITT RC, RABINOVITCH PS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331-8.
12. BROOME U, LINDBERG G, LOFBERG R. Primary sclerosing cholangitis in ulcerative colitis-A risk factor for the development of clysplasia and DNA aneuploidy- Gastroenterology 1992; 102: 1877-80.
13. BROOME U, LOFBERG R, VERESS B, ERIKSSON LS. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 22: 1404-8.
14. HIGASHI H, YANAGA K, MARSH JW, et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11:477-80.
15. KORNFELD D, EKBOMA, IBRET. Is there an excessive risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis- A population based study. Gut 1997; 41: 522-525.
16. RABINOVITZ M, GAVALER JS, SCHADE RR, et al. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease difer from that occurring in the absence of inflammatory bowel disease- A study of sixty-six subjects. Hepatology 1990; 11: 7-22.
17. WHITESIDE TL, LASKY S, SI L, VAN THIEL DH. Immunologic analysis os mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985;5:468-74.
18. WIESNER RH, GRAMBSCH PM, DICKSON ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
19. PORAYKOMK, LARUSSO NF, WIESNER RH. Primary sclerosing cholangitis: a progressive disease- Semin Liver Dis 1991; 11: 18-25.
20. PORAYKO MK, WIESNER RH, LARUSSO NF, et al. Patients with asymptomatic sclerosing cholangitis frequently have progressive disease. Gastroenterology 1990; 98: 1594-602.
21. LEFKOWITCH JH. Biliary atresia. Mayo Clin Proc 1998; 73: 90-5.
22. HEATHCOTE EJ. Chronic cholestasis in the adult clinical. AASLD Postgraduate Course 1998. Clinical and pathological correlations in liver diseases: approaching the next millennium. Chicago, 1998, pág. 222-230.
23. MEHTA SN, REINHOLD C, BARKUN AN. Magnetic resonance cholangiopancreatography. Gastrointestinal Endoscopy Clinics of North America 1997; 7: 247-70.
24. WIESNER RH. Current concepts in primary sclerosing 3 cholangitis. Mayo Clin Proc 1994; 69: 969-82.
25. BARISH MA, YUCEL EK, SOTO JA, et al. MR cholangiopancreatography: Efficacy of three dimensional turbo spin-echo technique. AJR 1995; 165: 295-300.
26. MCDERMOTT VG, NELSON RC. RE: MR cholangiopancreatography: Efficacy of three dimensional turbo spin-echo technique. Commentary. AJR 1995; 165: 301-2.
27. ERNST O, ASSELAH T, TALBODEC N, SERGENT G. MR cholangiopancreatography: A promising new tool for diagnosing primary sclerosing cholangitis. AJR 1997; 168: 1115-6.
28. LUDWIG J, BARHAM SS, LARUSSO NF, et al. Morphologic features of chronic hepatitis associated with primary sclerosing colangitis and chronic ulcerative colitis. Hepatology 1981; 1: 63240.
29. CHAPMAN RW, MARBORGH BA, RHODES JM, et al. Primary sclerosing cholangitis - a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870-7.
30. ALAM I, LEVENSON SD, FERREL LID, BASS NM. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature. Dig Dis Sci 1997; 42: 1295-1301.
31. GINSBERG GG, GOODMAN ZD, LEWIS JH. Diagnostic problems in clinical hepatology. A 22-year-old man with thyroid cancer and cholestatic liver disease. Semin Liver Dis 1991; 11: 64-71.
32. KEM ENY N, DALY J, REICHMAN B, et al. Intra-hepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal cancer. A randomized trial. Ann Intern Med 1987; 107:459-65.
33. LUDWIG J, KIM CH, WIESNER RH, et al. F!oxuridine induced sclerosing cholangitis: an ischemic cholangiopathy. Hepatology 1989; 9:215-8
34. WIESNER RH, LARUSSO NF, LUDWIG J, DICKSON R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88: 108-14.
35. BODENHEIMER HC, JR, LARUSSO NF, THAYER WR, JR, et al. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150-4.
36. QUIGLEY EMM, LARUSSO NF, LUDWIG J, et al. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983; 85: 1160-5.
37. VINNIK IE, KERN F Jr. Liver disease in ulcerative colitis. Arch Intern Med 1963; 112: 41-9.
38. FINEGOLD MJ, CARPENTER RJ. Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol 1982; 12: 662-5.
39. SNOVER DC, HORWITZ CA. Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxiclase study of six cases. Hepatology 1984; 4: 408-12.
40. MORECKI R, GLASER JH, CHO S, BALISTRERI WF, HORWITZ MS. Biliary atresia and reovirus type 3 infection. N Engl J Med 1982; 307: 481-4.
41. BODEN RW, RANKING JG, GOULSTON SJM, MORROW W. The liver in ulcerative colitis. The significance of raised serum-alkaline-phosphatase leves. Lancet 1959; 2: 245-8.
42. HOBSON CH, BUTT TJ, FERRY DM, et al. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 1988; 94: 1006-13.
43. KNOX TA, KAPLAN MM. Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol 1991; 86: 546-552.
44. PALMER KR, DUERDEN BI, HOLDSWORTH CID. Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 1980; 21: 851-854.
45. HODGSON SF, DICKSON ER, WAHNER HW et al. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985; 103: 855-60.
46. LICHTMAN SN, SARTOR RB, KEKU J, SCHWAB JH. Hepatic inflammation in rats with.
47. CANGEMI JR, WIESNER RH, BEAVER SJ, et al. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing colangitis. Gastroenterology 1989; 96: 790-4.
48. LINDOR KID, WIESNER RH, MACCARTY RL, LUDWIG J, LARUSSO NF. Advances in primary sclerosing cholangitis. Am J Med 1990; 89: 73-80.
49. MARTIN FM, ROSSI RL, NUGENT FW, et al. Surgical aspects of sclerosing cholangitis: results in 178 patients. Ann Surg 1990; 212: 551-8.
50. SIEGEL JH, BARN ES S, MORRIS JS. Bile acids in liver disease associated with inflammatory bowel disease. Digestion 1977; 15: 469-81.
51. BREWER GJ, YUZBASIYAN-GURKAN V. WILSON. Disease. Medicine 1992; 71: 139-64.
52. LARUSSO NF, WIESNER RH, LUDWIG J, et al. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988; 95: 1036-42.
53. AGUILAR HIA, NUAKO K, KROM RAF, WIESNER RH. Do primary sclerosing cholangitis (PSC) patients who express HLA DR4 haplotype have a more rapidly progressive disease- Hepatology 1994; 20:154.
54. CHAPMAN R. DOES HLA status influence prognosis in primary sclerosing cholangitis- Gastroenterology 1995; 108:937-40.
55. FARRANT JM, DOHERTY DG, DONALDSON PT, et al. Amino acid substitutions at position 38 of the DRbeta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992; 16: 390-5.
56. MEHAL WZ, LO Y-M D, WORDSWORTH BP, et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994; 106: 180-7.
57. CHAPMAN RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 1-4.
58. CHAPMAN RWG, KELLY PMA, HERYET A, JEWELL DP, FLEMING KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988; 29: 422-7.
59. DONALDSON PT, FARRANT JM, WILKINSON ML, et al. Dual association of HLA DR2 and HDL DR3 with primary sclerosing cholangitis. Hepatology 1991; 13: 129-33.
60. OLERUP O, OLSSON R, HULTCRANTZ R, BROOME U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995; 108: 870-8.
62. ALBERTI-FLOR JJ, DE MEDINA M, JEFFERS L, SCHIFF ER. Elevated immunogloublins and immune complexes in the bile of patients with primary sclerosing cholangitis. Hepatology 1983; 3: 844.
63. EL-SHABRAWI M, WILKINSON ML, PORTMAN B, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92: 1226-35.
64. SENALDI G, DONALDSON PT, MAGRIN S, et al. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1988; 97: 2430-4.
65. MINUK GY, ANGUS M, BRICKMAN EM, et al. Abnormal clearence of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985; 88: 166-70.
66. DAS KM, VECCHI M, SAKAMKIS S. A shared and unique epitope (s) on human colon, skin and biliary epithelium detected by monoclonal antibody. Gastroenterology 1990;98:464-9.
67. MANDAL A, DASGUPTA A, JEFFERS L, et al. Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994; 106: 185-92.
68. ARTLETT EM, SMITH JB, JIMENEZ AS. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998; 338: 1186-91.
69. MCDONNELL WM. Is primary biliary cirrhosis a complication of pregnancy- Hepatology 1998; 28: 593-4.
70. NELSON JL. Microchimerism and autoimune disease. N Engl J Med 1998; 338: 1224-5.
71. AMEDEE-MANESMEO, BRUNELLE F, HADCHOUEL M, BERNARD O, ALAGILLE D. Sclerosing cholangitis in infancy. Hepatology 1984; 4: 786A.
72. POUPON RE, BALKAU B, ESCHEWEGE E, POUPON R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324: 1548-54.
73. WIESNER RH, LUDWIG J, LARUSSO NF, MCCARTY RL. Diagnosis and treatment of primary sclerosing cholangitis. Semin Liv Dis 1985; 5: 241-53.
74. LOFTUS EV, JR, AGUILAR HI, SANDBORN WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27: 685-90.
75. KAPLAN MM. Medical approaches to primary sclerosing cholangitis. Semin Liver Dis 1991; 11:56-63. 
76. MAY GR, BENDER EC, LARUSSO NF, WIESNER RH. Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR Am J Roentgenol 1985; 145:1061-4.
77. MADDREY W, VAN THIEL DH. Liver transplantation: an overview. Hepatology 1988; 8: 948-959.
78. BORKJE B, VETVIK K, ODEGAARD S, et al. Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis. Scand J Gastroenterol 1985; 20: 539-42.
79. EPSTEIN O, CHAPMAN RWG, LAKE-BAKAAR G, et al. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology 1982; 83: 117782. 
80. HAY JE, WIESNER RH, SHORTER RG, LARUSSO NF, BALDU WP. Primary sclerosing cholangitis and celiac disease: a novel association. Ann Intern Med 1988; 109: 713-7.
81. LANSPA SJ, CHAN ATH, BELL JSA, III, et al. Pathogenesis of steatorrhea in primary biliary cirrhosis. Hepatology 1991; 14: 257-61.
82. WIESNER RH, LARUSSO NF, DOZOIS RR, BEABER SJ. Peristornal varices after proctocolectomy inpatients with primary sclerosing cholangitis. Gastroenterology 1986; 90: 316-22.
83. BALASUBRAMANIAM K, WIESNER RH, LARUSSO NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1988; 95: 1395-8.
84. LARUSSO NF, WIESNER RH, LUDWIG J, MACCARTHY RL. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899-903.
84. LEISER A, KADISH U. Case Report: beneficial effect of cholchicine in a case of sclerosing cholangitis. Am J Med Sci 1986; 291: 416-8.
85. KEEFE EB. Diagnosis of primary sclerosing cholangitis in a blood donor with elevated serum alaline aminotransferase. Gastroenterology 1989; 96:1358-9.
86. LUDWIG J, MACCARTHY RL, LARUSSO NF, KROM RAF, WIESNER RH. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangifis. Hepatology 1986; 6: 560-8
87. BHATAL PS, POWELL LW. Primary intrahepatic obliterating cholangitis: a possible variant of "sclerosing cholangitis". Gut 1969; 10: 886-93.
88. SCHEUER PJ. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 1998;73:179-83
89. SHERLOCKS. Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis 1991; 11: 5-10.
90. LUDWIG J. Small-duct primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 11-7.
91. HANAUER S. Primary sclerosing cholangitis and ulcerative colitis: potential cofators in the dysplasia sequence. Gastroenterology 1992; 102: 2161-2.
92. PAPATHEODORIDIS GV, HAMILTON M, MISTRY PK, et al. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998; 43: 639-44.
93. ROSS AP, BRAASCH JW. Ulcerative colitis and carcinoma of the proximal bile ducts. Gut 1973; 14: 94-7.
94. NARUMI S, ROBERTS JP, EMOND JC, LAKE J, ASCHER NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22: 451-7.
95. CHAPMAN RW. The colon and PSC: new liver, new danger- Gut 1998; 43: 595-6.
96. MARSH JW J, IWATSUKI S, MOKOWKA L, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988; 207: 21-5.
97. BRANDT DJ, MACCARTY RL, CHARBONEAU JW, et al. Gallbladder disease inpatients with primary sclerosing cholangitis. AJR Am J Roentgenol 1988; 571-4.
98. CARROLL BA, OPPENHEIMER DA. Sclerosing cholangitis: sonographic demonstration of bile duct wall thickening. AJR 1982; 139: 1016-1018.
99. Case Records of the Massachusetts General Hospital (Case 6-1982). N Engl J Med 1982; 306:349-58.
100. BERGQUIST A, GLAUMANN H, PERSSON B, BROOME U. Risk factor and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311-6.
101. MIR-MADJLESSI SH, FARMER RG, SIVAK MV. Bile duct carcinoma in patients with ulcerative colitis: report of six cases and review of the literature. Dig Dis Sci 1987; 32: 145-54.
102. ROSEN CB, NAGORNEY DM. Cholangiocarcinoma complicating primary sclerosing cholangitis. Sernin Liver Dis 1991; 11: 26-30.
103. ROSEN CB, NAGORNEY DM, WIESNER RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-25.
104. WEE A, LUDWIG J, COFFEY RJ, et al. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985; 16: 719-26.
105. RADERER M, MOLLER C, SCHEITHAUER W. Ondansetron for pruritus due to cholestasis. N Engl J Med 1994; 330: 1540.
106. RAMAGE JK, DONAGHY A, FARRANT JM, IORNNS R, WILLIAMS R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865-9.
107. LOFTUS EV JR, SANDBORN WJ, TREMAINE WJ, et al. Primary sclerosing cholangitis is associated with nonsmoking: case control study. Gastroenterology 1996; 110: 1496-1502.
108. VAN ERPECUM KJ, SM ITS SHJM, VAN DE M EEBERG PC, et al. Risk of primary sclerosing cholangitis is associated with nosmoking behavior. Gastroenterology 1996; 110: 1503-6.
109. DORUDI S, CHAPMAN RW, KETTLEWELL MGW. Carcinoma of the gallbladder in ulcerative colitis and primary sclerosing cholangitis. Report or two cases. Dis Colon Rectum 1991; 34: 827-8.
110. HAY JE, LINDOR KID, WIESNER RH, et al. Metabolic bone disease in primary sclerosing cholangitis. Hepatology 1991; 14: 257-61.
111. HEATHCOTE J. The clinical expression of primary biliary cirrhosis. Sem Liv Dis 1997; 17: 23-33.
112. BAYLINK DJ. Glucocorticoid-induced osteopenia. N Engl J Med 1983; 309: 306-8.
113. WEE A, LUDWIG J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts- Ann Intern Med 1985; 102: 581-7.
114. SCHNEIDERMAN DJ, CELLO JP, LANG FC. Papillary stenosis and sclerosing cholangitis in the acquired immunodeficiency syndrome. Ann Intern Med 1987; 106: 546-9.
115. DICKSON ER, MURTAUGH PA, WIESNER RH, et al. Primary sclerosing colangitis: refinement and validation of survival models. Gastroenterology 1992; 103: 1893-901.
116. FARRANT JM, HAYLLAR KN, WILKINSSON ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710-7.
117. CYNAMON HA, ANDRES JM, IAFRATE RP. Rifampicin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990; 98: 1013-16.
118. O'BRIEN CB, SENIOR JR, ARORA-MIRCHANDANI R, BATTA AK, SALEN G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology 1991; 14: 838-47.
119. PODESTA A, LÓPEZ P, TERG R, et al. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci 1989; 36: 216-20.
120. DATTA DV, SHERLOCK S. Cholestiramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 1966; 50: 323-32.
121. POLTER DE, GRUHLV, EIGENBRODT EH, COMBES B. Beneficial effect of cholestyramine in sclerosing cholangitis. Gastroenterology 1980; 79: 326-33.
122. BERGASA NV, SCHMITT JIM, TALBOT TL, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998; 27: 679-84.
123. BERGASA NV, JONES EA. The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. Gastroenterology 1995; 1582-5.
124. BERGASA NV, TALBOT TL, ALLING DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992; 102: 544-9.
125. JONES EA, BERGASA NV. Hypothesis. The pruritus of cholestasis: from bile acids to opiate agonists. Hepatology 1990; 11: 884-7.
126. SCHWORER H, RAMADORI G. Improvement of cholestatic pruritus by ondansetron. Lancet 1993; 341: 1277.
127. THORNTON JR, LOSOWSKY MS. Opioid peptides and primary biliary cirrhosis. Br Med J 1988; 297: 1501-4.
128. WOLFHAGEN FHJ, STERNIERI E, HOP WCJ, et al. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113: 1264-9.
129. BORGEAT A, WILDER-SMITH OHG, MENTHA G. Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology 1993; 104: 244-247.
130. EASTELR. Drug therapy: Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338: 736-46.
131. SCHREIBER AJ, SIMON FR. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 1983; 3: 607-13.
132. SARTIN JS, WIESNER RH, LARUSSO NF: Fat-soluble vitamin deficiencies in primary sclerosing cholangitis. Gastroenterology 1987; 92: 1615.
133. BEUERS U, SPENGLER U, KRUIS W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992; 16: 707-14.
134. HAYASHI H, HIGUCHI T, ICHIMIYA H, HISHIDA N, SAKAMOTO N. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 1990; 99: 533-5.
135. LINDOR K, DICKSON ER, BALDUS WP, et Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-90.
136. STIEHLA, RAEDSCH R, THELMANN L, GALLE P. The effect of ursodeoxycholic aci (UDCA) in primary sclerosing cholangitis (PSC). Gastroenterology, 1989; 96: A6-64.
137. LINDOR KD. Ursodiol for primary sclerosing cholangil:, N Engl J Med 1997; 336: 691-5.
138. BEUERS U, BOYER JL, PAUMGARTNE Ursodeoxycholic acid in cholestasis: potentil mechanisms of action and therapeutic application Hepatology 1998; 28: 1449-53.
139. KAPLAN MM. Toward better treatment of primary sclerosing cholangitis. N Engl J Med 1997; 336: 719-2.
140. KAPLAN MM. Gastro 99, Practiotioners Program, Cholestasis Symposium, Vancouver, 1999.
141. COTTON PB, NICKL N. Endoscopic and radiology approaches to therapy in primary sclerosing cholangitis. Semin Liver Dis 1991; 11:40-8.
142. MILLIGEN DE WIT AWM, RAWS EA, VAN BRACHT J, et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in prima sclerosing cholangitis. Gastrointest Endosc 1996; 44: 293-9.
143. LILLEMOE KD, CAMERON JL. Surgical approaches primary sclerosing cholangitis. Semin Liver D 1991; 11: 49-55.
144. WIESNER RH, PORAYKO MK, DICKSON ER, et a Selection and timing of liver transplantation in prima biliary cirrhosis and primary sclerosing cholangitis Hepatology 1992; 16: 1290-9.
145. National Institutes of Health Consensus Development Conference Statement: Liver Transplantation - Jun 20-23, 1983. Hepatology 1984; 4: 107S-110S.
146. GRAZIDEI IW, WIESNER RH, MAROTTA PJ, et al. Strong evidence for recurrence or primary sclerosing cholangitis after liver transplantation. Hepatology 1997; 26: 176-A.

REGRESAR AL ARTÍCULO